Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Simoens

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Journal of Clinical Pharmacy and Therapeutics|August 5, 2011
What is the value for money of medicines? A registry studyS Simoens
Allergy|July 7, 2012
The cost-effectiveness of immunotherapy for respiratory allergy: a reviewS Simoens
Journal of Clinical Pharmacy and Therapeutics|December 21, 2006
Using the Delphi technique in economic evaluation: time to revisit the oracle?S Simoens
Journal of Clinical Pharmacy and Therapeutics|May 7, 2011
How much is the life of a cancer patient worth? A pharmaco-economic perspectiveS Simoens, M Dooms
Allergy|December 17, 2008
Pharmacotherapy of allergic rhinitis: a pharmaco-economic approachS Simoens, G Laekeman
Gene Therapy|September 8, 2017
Market access of Spinraza (Nusinersen) for spinal muscular atrophy: intellectual property rights, pricing, value and coverage considerationsS Simoens, I Huys
Scottish Medical Journal|September 19, 2002
Job satisfaction, work-related stress and intentions to quit of Scottish GPSS Simoens, A Scott, B Sibbald
Journal of Clinical Pharmacy and Therapeutics|September 15, 2012
Do we need authorized orphan drugs when compounded medications are available?M Dooms, H Pincé, S Simoens
Health Policy (Amsterdam, Netherlands)|June 23, 2000
Evaluating the effect of new hospital specialties on GP prescription costsS Simoens, C Gordon, A Scott
Journal De Pharmacie De Belgique|November 25, 2010
[Medicine information for patients with a major depression at hospital discharge]F Desplenter, G Laekeman, S Simoens
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Journal of Clinical Pharmacy and Therapeutics|August 5, 2011
What is the value for money of medicines? A registry studyS Simoens
Allergy|July 7, 2012
The cost-effectiveness of immunotherapy for respiratory allergy: a reviewS Simoens
Journal of Clinical Pharmacy and Therapeutics|December 21, 2006
Using the Delphi technique in economic evaluation: time to revisit the oracle?S Simoens
Journal of Clinical Pharmacy and Therapeutics|May 7, 2011
How much is the life of a cancer patient worth? A pharmaco-economic perspectiveS Simoens, M Dooms
Allergy|December 17, 2008
Pharmacotherapy of allergic rhinitis: a pharmaco-economic approachS Simoens, G Laekeman
Gene Therapy|September 8, 2017
Market access of Spinraza (Nusinersen) for spinal muscular atrophy: intellectual property rights, pricing, value and coverage considerationsS Simoens, I Huys
Scottish Medical Journal|September 19, 2002
Job satisfaction, work-related stress and intentions to quit of Scottish GPSS Simoens, A Scott, B Sibbald
Journal of Clinical Pharmacy and Therapeutics|September 15, 2012
Do we need authorized orphan drugs when compounded medications are available?M Dooms, H Pincé, S Simoens
Health Policy (Amsterdam, Netherlands)|June 23, 2000
Evaluating the effect of new hospital specialties on GP prescription costsS Simoens, C Gordon, A Scott
Journal De Pharmacie De Belgique|November 25, 2010
[Medicine information for patients with a major depression at hospital discharge]F Desplenter, G Laekeman, S Simoens
Pageof 3